2007
Restalyst Pte Ltd was founded.
Launch of the Restalyst’s nasopharyngeal carcinoma diagnostic kit(NPC-REAAD)
2009
Restalyst’s R&D and production facilities achieved ISO13485 certification.
2011
NPC-REAAD received CE marking.
2012
NPC-REAAD listed on Singapore Medical Device Register.
2015
Restalyst launched gastric carcinoma diagnostic kit (GC-REAAD).
GC-REAAD received CE marking.
ResteLab acquired The Clinical Laboratory.
2016
ResteLab received approval from Singapore Ministry of Health and commenced operations.
ResteLab officially opened a facility in central Hong Kong.
Restalyst launched hepatocellular carcinoma diagnostic kit (HCC-REAAD). HCC-REAAD received CE marking.
2017
GC-REAAD listed on Singapore Medical Device Register.